Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
JACC. Cardiovascular Interventions
|
November 5, 2021
Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population
Saurav Chatterjee, Alexander C Fanaroff, Craig Parzynski, et al.
Circulation
|
December 20, 2018
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
Andrew P Ambrosy, Craig S Parzynski, Daniel J Friedman, et al.
Annals of Internal Medicine
|
May 3, 2016
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study
Isuru Ranasinghe, Craig S Parzynski, James V Freeman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 21, 2022
Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries
Samuel W Reinhardt, Katherine A A Clark, Xin Xin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 31, 2024
Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD)
Bradley S Miller, Jane Loftus, Mona Kelkar, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 6, 2014
Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry
Steven M Bradley, Sunil V Rao, Jeptha P Curtis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 9, 2022
Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency
Jane Loftus, Bradley S Miller, Craig S Parzynski, et al.
Circulation
|
February 22, 2018
Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry
Daniel J Friedman, Craig S Parzynski, E Kevin Heist, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
February 12, 2025
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication
Jane Loftus, Bradley S Miller, Craig S Parzynski, et al.
Journal of the American Heart Association
|
January 16, 2019
Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes
Philip W Chui, Craig S Parzynski, Joseph S Ross, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
JACC. Cardiovascular Interventions
|
November 5, 2021
Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population
Saurav Chatterjee, Alexander C Fanaroff, Craig Parzynski, et al.
Circulation
|
December 20, 2018
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
Andrew P Ambrosy, Craig S Parzynski, Daniel J Friedman, et al.
Annals of Internal Medicine
|
May 3, 2016
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study
Isuru Ranasinghe, Craig S Parzynski, James V Freeman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 21, 2022
Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries
Samuel W Reinhardt, Katherine A A Clark, Xin Xin, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 31, 2024
Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD)
Bradley S Miller, Jane Loftus, Mona Kelkar, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 6, 2014
Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry
Steven M Bradley, Sunil V Rao, Jeptha P Curtis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 9, 2022
Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency
Jane Loftus, Bradley S Miller, Craig S Parzynski, et al.
Circulation
|
February 22, 2018
Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry
Daniel J Friedman, Craig S Parzynski, E Kevin Heist, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
February 12, 2025
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication
Jane Loftus, Bradley S Miller, Craig S Parzynski, et al.
Journal of the American Heart Association
|
January 16, 2019
Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes
Philip W Chui, Craig S Parzynski, Joseph S Ross, et al.
Page
of 6